Clene Nanomedicine, Inc
6550 S. Millrock Dr.
Salt Lake City
About Clene Nanomedicine, Inc
Clene is transforming medicine through the application of physics and material science to resolve cellular bioenergetic failure. Our objective is not only to treat patients with neurodegenerative disease but to empower them by harnessing the power of nanocrystalline catalysts to reverse degenerative mechanisms. Clene is rapidly advancing a pipeline of bioenergetic nanotherapeutics designed to enhance naturally occurring cellular metabolism with the goal of reversing neurodegeneration.
Stock Symbol: CLNN
1 article with Clene Nanomedicine, Inc
Clene Inc. and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to revolutionizing the treatment of neurodegenerative disease using nanocatalysis, reported its full year 2020 operating and financial results.